
Internet Of Medical Things (Iomt) Market By Component (Hardware, Wearable Devices, Stationary Devices, Implantable Devices, Others),By Deployment Mode (On-premise, Cloud), By Application (Telemedicine, Clinical Operations & Workflow Management, Connected Imaging, Medication Management, Inpatient Monitoring, Others), By End-use (Homecare, Clinics, Hospitals, Research Institutes & Academics, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
-
46149
-
April 2024
-
136
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Global Internet Of Medical Things (Iomt) Market was valued at USD 176.1 Bn in 2023. It is expected to reach USD 1,263.6 Bn by 2033, with a CAGR of 22.4% during the forecast period from 2024 to 2033.
The Internet of Medical Things (IoMT) market refers to the interconnected network of medical devices and applications that collect and transmit health data through the internet for analysis and decision-making. IoMT encompasses a wide range of technologies, including wearable devices, remote patient monitoring systems, and smart healthcare infrastructure. By enabling real-time monitoring and data-driven insights, IoMT solutions revolutionize patient care, enhance clinical outcomes, and optimize healthcare delivery. This rapidly evolving market presents immense opportunities for healthcare organizations to improve efficiency, reduce costs, and deliver personalized care experiences, ultimately shaping the future of healthcare delivery and management.
The Internet of Medical Things (IoMT) represents a disruptive force in the healthcare ecosystem, poised to redefine patient care delivery and operational efficiency. As analysts, our assessment of the IoMT market underscores its transformative potential, bolstered by Forbes' estimation of 646 million IoT devices deployed within healthcare facilities in 2020. This proliferation of connected medical devices underscores the industry's inclination towards digitalization, heralding a new era of connected healthcare solutions.
Research findings further validate IoMT's value proposition, with studies indicating a remarkable 50% reduction in hospital readmission rates facilitated by IoMT solutions. Such statistics underscore the tangible benefits IoMT offers in enhancing patient outcomes and driving operational efficiencies. Leveraging real-time data analytics and remote patient monitoring capabilities, IoMT solutions empower healthcare providers to deliver personalized care interventions, thereby mitigating health risks and improving overall patient well-being.
Amidst the promising growth trajectory, challenges persist, including data security concerns, interoperability issues, and regulatory complexities. These factors necessitate a holistic approach to IoMT implementation, encompassing robust cybersecurity measures, interoperable standards, and adherence to regulatory guidelines. Moreover, as market dynamics evolve, stakeholders must continuously innovate to stay ahead of the curve and capture emerging opportunities in this dynamic landscape.
Key Takeaways
- Market Growth: The Global Internet Of Medical Things (Iomt) Market was valued at USD 176.1 Bn in 2023. It is expected to reach USD 1,263.6 Bn by 2033, with a CAGR of 22.4% during the forecast period from 2024 to 2033.
- By Component: Hardware dominates the IoMT market with a 48.2% share, driven by advanced medical devices and robust connectivity solutions.
- By Deployment Mode: On-premise solutions lead with 56.4%, preferred for their security, control, and compliance advantages in healthcare facilities.
- By Application: Telemedicine applications hold 32.1% of the market, highlighting the growing importance of remote patient monitoring and virtual care.
- By End-User: Hospitals account for 33.2% of IoMT usage, leveraging connected technologies to enhance patient care, diagnostics, and operational efficiency.
- Regional Dominance: North America leads with 42.3% of the IOMT market share, driven by advanced healthcare infrastructure and rapid technology adoption.
- Growth Opportunity: Significant growth opportunities exist in the IOMT market through advancements in AI integration, expanding telemedicine services, and increased investment in remote patient monitoring technologies.
Driving factors
Advancements in Healthcare IT
The rapid advancement in healthcare IT is serving as a catalyst for the exponential growth of the Internet of Medical Things (IoMT) market. With cutting-edge technologies like artificial intelligence, machine learning, and big data analytics becoming increasingly integrated into healthcare systems, the IoMT is leveraging these innovations to enhance patient care, streamline processes, and improve overall efficiency.
These advancements enable seamless integration of medical devices, wearables, and sensors into existing healthcare infrastructure, facilitating real-time monitoring, data collection, and analysis. For instance, wearable devices equipped with IoMT capabilities can continuously monitor vital signs, track medication adherence, and even predict potential health issues, thereby empowering both patients and healthcare providers with actionable insights for proactive intervention.
Fostering Collaboration and Synergy
Partnerships among various stakeholders, including healthcare providers, technology companies, device manufacturers, and regulatory bodies, play a pivotal role in driving the growth of the IoMT market. Collaborative efforts between these entities facilitate the development of interoperable solutions, standards, and protocols, thereby overcoming interoperability challenges and ensuring seamless integration of IoMT devices into healthcare ecosystems.
End-user engagement is particularly critical in shaping the design, functionality, and usability of IoMT solutions to meet the evolving needs and preferences of healthcare professionals and patients. Through strategic partnerships, industry players can co-create tailored IoMT solutions that address specific clinical workflows, improve patient engagement, and drive better health outcomes.
Investments in IoT by Companies and Governments
Significant investments by both private companies and governments in IoT infrastructure, research, and development are fueling the expansion and adoption of IoMT technologies worldwide. As companies recognize the immense market potential and societal impact of IoMT, they are allocating substantial resources towards product innovation, market expansion, and strategic acquisitions to gain a competitive edge in this burgeoning sector.
Government initiatives and funding support further amplify the growth trajectory of the IoMT market by fostering an ecosystem conducive to innovation, entrepreneurship, and investment. Public-private partnerships, grants, tax incentives, and regulatory frameworks aimed at promoting the adoption of IoT and digital health technologies incentivize companies to develop IoMT solutions that address healthcare challenges while ensuring compliance with regulatory requirements.
Restraining Factors
Addressing Data Security Concerns and Cyberattacks
As the Internet of Medical Things (IoMT) market expands, so do concerns surrounding data security and cyber threats. With the proliferation of connected medical devices and the vast amounts of sensitive patient data they generate, ensuring robust cybersecurity measures is paramount to safeguarding patient privacy and maintaining trust in IoMT technologies.
Lack of Universal Standards and Fragmentation
One of the primary challenges facing the IoMT market is the lack of universal standards and fragmentation within the ecosystem. The absence of standardized protocols for data exchange and device interoperability hampers seamless integration and increases vulnerability to cyber threats. Addressing this challenge requires industry-wide collaboration to develop and implement interoperability standards that prioritize security, privacy, and data integrity across IoMT devices and platforms.
Increasing Cyber-Attacks on Healthcare Data
The healthcare sector has become an attractive target for cybercriminals due to the high value of medical data and the potential for financial gain. As cyber-attacks on healthcare data continue to rise, IoMT stakeholders must prioritize cybersecurity measures to mitigate risks and protect against data breaches. Implementing robust encryption techniques, access controls, and authentication mechanisms can fortify IoMT systems against unauthorized access and data theft.
By Component
Hardware established supremacy in the Component segment of the Internet of Medical Things (IoMT) market, commanding a market share exceeding 48.2%.
In 2023, Hardware held a dominant market position in the Internet of Medical Things (IoMT) market, particularly within the Wearable Devices segment, capturing more than a 48.2% share. This underscores the pivotal role of hardware components in driving innovation and adoption within the IoMT ecosystem.
Stationary Devices, while exhibiting promising growth potential, trailed behind Wearable Devices in market share within the Hardware segment. Despite this, they remained integral components in clinical settings, enabling advanced monitoring and diagnostics within healthcare facilities.
Implantable Devices represented another noteworthy segment within the Hardware category, albeit with a smaller market share compared to Wearable and Stationary Devices. These sophisticated devices, designed to be implanted within the human body for continuous monitoring and treatment, offered unparalleled insights into patients' health metrics.
The "Others" category encompassed a diverse range of hardware components contributing to the IoMT landscape. This category included specialized medical sensors, connectivity modules, and supporting hardware infrastructure vital for IoMT system functionality.
By Deployment Mode
On-premise solutions asserted dominance in the Deployment Mode segment of the Internet of Medical Things (IoMT) market, capturing more than 56.4% market share.
In 2023, On-premise held a dominant market position in the Internet of Medical Things (IoMT) market, specifically within the Deployment Mode segment, capturing more than a 56.4% share. This underscores the preference for localized infrastructure and data management solutions among healthcare providers and stakeholders in the IoMT ecosystem.
Cloud-based deployment, while experiencing notable growth and adoption, trailed behind On-premise solutions in market share within the Deployment Mode segment. Despite the advantages of scalability, flexibility, and cost-effectiveness associated with cloud-based platforms, concerns regarding data privacy, security, and regulatory compliance persisted among healthcare providers.
By Application
Telemedicine emerged as the leading application segment in the Internet of Medical Things (IoMT) market, capturing a commanding 32.1% market share.
In 2023, Telemedicine held a dominant market position in the Internet of Medical Things (IoMT) market, particularly within the Application segment, capturing more than a 32.1% share. This underscores the pivotal role of telehealth technologies in transforming healthcare delivery and patient engagement within the IoMT ecosystem.
Clinical Operations & Workflow Management represented another critical segment within the IoMT Application landscape, albeit with a slightly smaller market share compared to Telemedicine. These solutions focused on optimizing healthcare workflows, streamlining administrative tasks, and improving operational efficiency within healthcare facilities.
Connected Imaging, leveraging advanced imaging technologies and data analytics, emerged as a key application segment facilitating real-time diagnostic imaging and interpretation. While constituting a smaller portion of the overall Application segment, Connected Imaging played a crucial role in enhancing clinical decision-making, treatment planning, and patient outcomes through access to high-quality imaging data anytime, anywhere.
Medication Management solutions addressed medication adherence, dosage monitoring, and medication reconciliation challenges, thereby promoting medication safety and patient compliance.
Inpatient Monitoring solutions encompassed a range of IoMT-enabled devices and platforms designed to monitor patients' vital signs, physiological parameters, and health status within clinical settings.
By End-use
Hospitals dominated the Internet of Medical Things (IoMT) market within the End-use segment, securing over 33.2% market share.
In 2023, Hospitals held a dominant market position in the Internet of Medical Things (IoMT) market, particularly within the End-use segment, capturing more than a 33.2% share. This underscores the pivotal role of hospitals as primary adopters and beneficiaries of IoMT technologies, driving advancements in patient care, operational efficiency, and healthcare delivery.
Homecare, while experiencing notable growth and adoption, trailed behind hospitals in market share within the End-use segment. However, the homecare segment showcased considerable potential for expansion, driven by the growing trend towards remote patient monitoring, telehealth, and personalized healthcare delivery. Clinics represented another critical segment within the IoMT End-use landscape, catering to outpatient care, specialty services, and preventive healthcare interventions. These facilities adopted IoMT solutions to streamline operations, improve patient engagement, and optimize care delivery processes.
Research Institutes & Academics focused on advancing medical research, innovation, and education through the integration of IoMT technologies into research protocols and academic curricula. These institutions served as incubators for cutting-edge IoMT solutions, fostering collaboration between academia, industry, and healthcare practitioners.
Furthermore, the "Others" category encompassed a diverse array of end-users, including long-term care facilities, rehabilitation centers, and healthcare service providers outside traditional hospital and clinic settings.
Key Market Segments
By Component
- Hardware
- Wearable Devices
- Stationary Devices
- Implantable Devices
- Others
By Software
- Device Management
- Application Management
- Cloud Management
- Data Analytics
- Others
By Services
- Integration & Deployment
- Consulting
- Support & Maintenance
By Deployment Mode
- On-premise
- Cloud
By Application
- Telemedicine
- Clinical Operations & Workflow Management
- Connected Imaging
- Medication Management
- Inpatient Monitoring
- Others
By End-use
- Homecare
- Clinics
- Hospitals
- Research Institutes & Academics
- Others
Growth Opportunity
Advancements in Healthcare IT
The landscape of healthcare is evolving at a remarkable pace, driven by advancements in healthcare IT that are revolutionizing patient care. With increasing awareness among consumers about the importance of proactive healthcare management and preventive measures, the demand for innovative diagnostic solutions is soaring. IoMT technologies are at the forefront of this transformation, offering personalized, data-driven insights that empower individuals to take charge of their health and well-being.
Government support for IoMT device approvals streamlines the regulatory pathway, reducing time-to-market and enabling faster adoption of these technologies. This regulatory backing instills confidence among healthcare providers and end-users regarding the safety, efficacy, and interoperability of IoMT solutions, thereby accelerating market growth.
Partnerships among Players and End-Users
Strategic partnerships among healthcare providers, technology companies, and regulatory bodies are fostering collaboration and synergy within the IoMT ecosystem. By aligning their expertise and resources, stakeholders can co-create tailored IoMT solutions that address specific clinical needs and enhance patient outcomes. This collaborative approach not only accelerates innovation but also ensures the seamless integration of IoMT devices into existing healthcare workflows.
Investments in infrastructure, such as 5G service and cloud infrastructure service, bolster the connectivity and scalability of IoMT ecosystems, unlocking new opportunities for market expansion. These investments facilitate real-time data transmission, advanced analytics, and remote monitoring capabilities, enabling IoMT solutions to penetrate diverse healthcare settings and deliver value across the care continuum.
Latest Trends
Expansion of Telehealth and Virtual Care
The year 2024 marks a significant turning point for the IoMT market, with the continued expansion of telehealth and virtual care emerging as a dominant trend. Accelerated by the global COVID-19 pandemic, telehealth adoption has surged, driven by the need for remote patient monitoring, virtual consultations, and telemedicine services.
IoMT technologies play a pivotal role in enabling the seamless delivery of telehealth solutions, facilitating real-time data capture, remote diagnostics, and patient engagement. As healthcare providers increasingly embrace telehealth platforms to improve accessibility, convenience, and efficiency of care delivery, IoMT solutions are poised to experience unprecedented growth and adoption.
Rising Demand for Mobile Healthcare Tech
Another key trend shaping the IoMT market in 2024 is the rising demand for mobile healthcare technologies. With the proliferation of smartphones, wearables, and IoT-enabled devices, consumers are increasingly seeking personalized, on-the-go healthcare solutions that empower them to monitor their health and well-being anytime, anywhere.
IoMT devices equipped with mobile connectivity and user-friendly interfaces are driving this trend, offering individuals unprecedented access to health information, wellness insights, and remote monitoring capabilities. From fitness trackers and smartwatches to mobile women's health apps and connected medical devices, the IoMT ecosystem is witnessing a surge in innovative mobile healthcare technologies that cater to diverse consumer needs and preferences.
Regional Analysis
North America leads the IoMT market with 42.3% dominance, buoyed by advanced healthcare infrastructure and strong governmental backing.
North America stands as the dominant force in the Internet of Medical Things (IoMT) market, commanding a substantial share of approximately 42.3%. This leadership is underpinned by advanced healthcare infrastructure, widespread adoption of digital technologies in healthcare, and robust governmental backing for IoMT initiatives. The region's IoMT landscape is marked by a surge in remote patient monitoring, wearable devices, and telehealth services. With key market players and significant R&D investments, North America is poised to maintain its leading position in the IoMT market.
Europe emerges as a formidable contender in the IoMT arena, boasting a well-established healthcare infrastructure and a burgeoning appetite for digital health solutions. Germany, the UK, and France spearhead IoMT adoption, buoyed by increasing healthcare expenditure, favorable government policies, and a growing elderly population. The European IoMT market is on a trajectory of robust growth, propelled by advancements in connected medical devices, interoperable healthcare systems, and data analytics.
The Asia Pacific region represents a promising frontier for IoMT, driven by rapid urbanization, escalating healthcare spending, and heightened awareness of connected healthcare solutions. Countries like China, Japan, and India are witnessing significant investments in digital health infrastructure, spurred by the proliferation of smartphones, expanding internet penetration, and rising chronic disease prevalence. IoMT solutions are poised for substantial uptake in the region, fueled by a convergence of favorable demographics and technological advancements.
In the Middle East & Africa, IoMT adoption is gaining traction, albeit at a gradual pace, driven by endeavors to enhance healthcare accessibility, patient outcomes, and operational efficiency. Nations like the UAE, Saudi Arabia, and South Africa are leading the charge in IoMT adoption, propelled by digital healthcare initiatives and telemedicine infrastructure investments.
Latin America is witnessing a burgeoning interest in IoMT, fueled by increasing healthcare spending, rising chronic disease prevalence, and efforts to revamp healthcare delivery systems. Countries such as Brazil, Mexico, and Argentina are witnessing a surge in demand for connected healthcare solutions, driven by initiatives to enhance healthcare access and patient outcomes.
Key Regions and Countries
North America
- US
- Canada
- Mexico
Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
In 2024, the global Internet of Medical Things (IoMT) market is witnessing intense competition among key players, each striving to carve out a significant share in this rapidly evolving landscape. Among these key companies, Microsoft Corporation stands out as a formidable force, leveraging its expertise in cloud computing, data analytics, and artificial intelligence (AI) to drive innovation in connected healthcare solutions. With its Azure cloud platform and HealthBot AI technology, Microsoft is empowering healthcare providers to harness the potential of IoMT, enabling seamless data integration, real-time monitoring, and personalized patient care.
Biotronik SE & Co. KG emerges as another influential player, renowned for its expertise in medical devices and implantable technologies. By integrating connectivity features into its product portfolio, Biotronik is at the forefront of the IoMT revolution, offering advanced solutions for cardiac monitoring, remote patient management, and predictive analytics.
Johnson & Johnson Services, Inc. is making significant strides in the IoMT space, leveraging its diverse portfolio of healthcare products and services. Through strategic partnerships and investments in digital health initiatives, Johnson & Johnson is driving innovation across the care continuum, from diagnostics and treatment to patient engagement and post-acute care.
Koninklijke Philips N.V. remains a dominant player in the IoMT market, capitalizing on its legacy of innovation in healthcare technology. With a focus on connected devices, telehealth solutions, and population health management, Philips is empowering healthcare organizations to deliver better outcomes and experiences for patients worldwide.
Apple, Inc. continues to disrupt the healthcare industry with its ecosystem of consumer devices and health-focused applications. By leveraging the capabilities of Apple Watch, iPhone, and HealthKit platform, Apple is enabling users to monitor their health, track fitness metrics, and share data with healthcare providers seamlessly.
Boston Scientific Corporation, Lenovo Group Ltd., Cisco Systems, Inc., General Electric Company, Honeywell International Inc., IBM Corporation, Medtronic plc, Neurometrix, Inc., SAP SE, and Siemens AG are also key players contributing to the growth and innovation in the IoMT market, each bringing unique strengths and capabilities to address the evolving needs of healthcare stakeholders globally. As the IoMT market continues to expand and mature, these key players are expected to play a pivotal role in shaping the future of connected healthcare delivery and patient outcomes.
Market Key Players
- Microsoft Corporation
- Biotronik SE & Co. KG
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Apple, Inc.
- Boston Scientific Corporation
- Lenovo Group Ltd.
- Cisco Systems, Inc.
- General Electric Company
- Honeywell International Inc.
- IBM Corporation
- Medtronic plc
- Neurometrix, Inc.
- SAP SE
- Siemens AG
Recent Development
- In May 2024, Medtronic: Acquired Companion Medical, a company specializing in smart insulin pens and diabetes management solutions.
- In June 2024, Philips: Invested in Biofourmis, a digital therapeutics company focusing on personalized patient care.
- In July 2024, Siemens Healthineers Partnered with Cardiologs, an AI-powered cardiology diagnostics company.
Report Scope
Report Features Description Market Value (2023) USD 176.1 Bn Forecast Revenue (2033) USD 1,263.6 Bn CAGR (2024-2033) 22.4% Base Year for Estimation 2023 Historic Period 2018-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Component (Hardware, Wearable Devices, Stationary Devices, Implantable Devices, Others), By Software (Device Management, Application Management, Cloud Management, Data Analytics, Others), By Services (Integration & Deployment, Consulting, Support & Maintenance), By Deployment Mode (On-premise, Cloud), By Application (Telemedicine, Clinical Operations & Workflow Management, Connected Imaging, Medication Management, Inpatient Monitoring, Others), By End-use (Homecare, Clinics, Hospitals, Research Institutes & Academics, Others) Regional Analysis North America - The US, Canada, & Mexico; Western Europe - Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe - Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC - China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America - Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa - Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Microsoft Corporation, Biotronik SE & Co. KG, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Apple, Inc., Boston Scientific Corporation, Lenovo Group Ltd., Cisco Systems, Inc., General Electric Company, Honeywell International Inc., IBM Corporation, Medtronic plc, Neurometrix, Inc., SAP SE, Siemens AG Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
-
- Microsoft Corporation
- Biotronik SE & Co. KG
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Apple, Inc.
- Boston Scientific Corporation
- Lenovo Group Ltd.
- Cisco Systems, Inc.
- General Electric Company
- Honeywell International Inc.
- IBM Corporation
- Medtronic plc
- Neurometrix, Inc.
- SAP SE
- Siemens AG